Senescent Fibroblasts Generate a CAF Phenotype through the Stat3 Pathway.

Area of Science:

• Cellular senescence
• Cancer biology
• Fibroblast research

Background:

• Aging is linked to increased lung cancer risk.
• Senescent fibroblasts can adopt a cancer-associated fibroblast (CAF) phenotype.
• The mechanisms connecting fibroblast senescence to CAF activation are not well understood.

Purpose of the Study:

• To investigate how fibroblast senescence leads to CAF activation.
• To explore the role of the Stat3 pathway in this process.
• To identify potential therapeutic targets for lung cancer.

Main Methods:

• Characterization of senescent fibroblasts for CAF markers (α-SMA, Vimentin) and factors (CXCL12, FGF10, IL6, COL1A1).
• Assessment of collagen contractile activity, and lung cancer cell migration and invasion.
• Investigation of the Stat3 pathway activation by intracellular ROS during senescence.

Main Results:

• Senescent fibroblasts exhibited CAF properties, including elevated CAF markers and factors.
• These senescent fibroblasts increased collagen contraction and promoted lung cancer cell migration and invasion.
• The Stat3 pathway, activated by ROS, was found to regulate CAF characteristics in senescent fibroblasts.

Conclusions:

• Senescent fibroblasts mediate CAF functions through the Stat3 pathway.
• ROS accumulation during senescence activates Stat3, driving CAF phenotypes.
• A novel Stat3-dependent mechanism is identified, potentially targetable for inhibiting lung cancer progression.